Popular Stories

FDA Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Emerging Therapeutics in Preeclampsia Management

Preeclampsia is a pregnancy related complication that affects over 5% to 8% of pregnancies or about 3,00,000 women in the US alone. An estimated 10,500 babies in the U.S, succumb to preeclampsia while others suffer from extensive damage owing to premature delivery. It is one of...

Cyberdyne – Changing Paradigms of Exoskeleton Market

Cyberdyne’s (OTC Pink: CYBQY)  HAL (Hybrid Assistive Limb) lower-body exoskeleton, touted to be the world’s first cyborg – type robot, received a FDA approval to start offering its exoskeleton in the U.S through licensed medical facilities in January 2018. This device can support, enhance and...

MUSTANG BIO: SOARING TO A NEW HIGH AFTER BUBBLE BOY CURE ANNOUNCEMENT

Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results that demonstrated that its experimental gene therapy could cure “Bubble Boy” disease or X-SCID, a severe combined immunodeficiency in infants. Figure 1 - Stock...

Is Autologous Stem Cell Therapy the next frontier of medicine?

Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of the regenerative powers of stem cells, along with rising research and development expenditure on stem cell technology will drive the growth...

WordPress Video Lightbox Plugin